Skip to content

The Effect of Desflurane on Postopertative Cognitive Dysfunction

A Study Evaluating the Effect of Desflurane in Preventing Postoperative Cognitive Dysfunction

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04541823
Enrollment
100
Registered
2020-09-09
Start date
2021-05-01
Completion date
2023-03-31
Last updated
2021-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Cognitive Dysfunction, Postoperative Delirium

Brief summary

The purpose of this study is to determine the effect of desflurane on postoperative cognitive dysfunction

Detailed description

Postoperative cognitive dysfunction is a common complication during postoperative period,especially in elderly patients. It is characterized by cognitive decline, inattention and abnormal mental status following surgery. The presence of postoperative cognitive dysfunction is independently associated with poor recovery, increased hospital length of stay and increased mortality. Desflurane is a widely used volatile anesthetic, associated with shorter emergence times than other volatile anesthetics. This study aims to access the effect of desflurane in preventing postoperative cognitive dysfunction.

Interventions

Investigators administrated desflurane with target of BIS 40-60 during the maintenance of anesthesia

DRUGPropofol

Investigators administrated propofol with target of BIS 40-60 during the maintenance of anesthesia

Sponsors

Beijing Chao Yang Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 1\. Written consent given * 2\. Scheduled to undergo elective non-cardiac surgeries under general anesthesia * 3\. ASA Physical Score I-III

Exclusion criteria

* 1\. Patients with a history of neurological disease, such as Alzheimer disease. * 2\. Patients with a history of psychiatric disease * 3\. Patients with a medication history of antipsychotic drugs. * 4\. Unable to complete neuropsychological testing including patients with severe visual or hearing impairment. * 5\. Patients with preoperative delirium. * 6\. Patients who have severe adverse events, such as cardiac arrest. * 7\. Patients who preoperative MMSE score are below 20; * 8\. Patients who undergo second operation in a short period.

Design outcomes

Primary

MeasureTime frameDescription
Incidence of postoperative cognitive dysfunctionon the 30th day after surgeryScreening of the patients regarding an postoperative cognitive dysfunction by TICS-M.TICS-M is assessed at 30 days after surgery

Secondary

MeasureTime frameDescription
Postoperative PainWithin 3 days after surgeryVisual Analogue Scale will be used to assess postoperative pain of patients. Numerical rating scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain.
EEG frequency spectrum5 minutes before anesthesia introduction to 5 minutes before discharge from PACUElectroencephalography will be recorded at different points of time as follows and EEG characteristics including power in alpha, beta, theta, delta, gamma, spectrum will be extracted using MATLAB: 1. Five minutes before anesthesia introduction 2. During the entire operation 3. At discharge from post-anesthesia care unit (PACU)
MortalityWithin 30 days after surgery
Length of Hospital stayFrom the date of admission until discharged from hospital, within 30 days
Incidence of postoperative delirium1-7days after surgery, on the 30th day after surgeryScreening of the patients regarding a postoperative delirium by The Confusion Assessment Method for The Intensive Care Unit (CAM-ICU)
Incidence of postoperative nausea and vomitingWithin 7 days after surgery
Adverse eventsWithin 30 days after surgeryOther adverse events within 3 days after surgery were noted
Neural and hemodynamic responses during desflurane general anesthesia5 minutes before anesthesia introduction to 5 minutes after emergenceFunctional near-infrared spectroscopy (fNIRS) will be monitored from pre-anesthesia to the emergence. △\[HbO\] ,△\[Hb\] will be recorded. Besides, the coupling of fNIRS signals with neuronal signals (EEG) will be calculated. Furthermore, sample entrophy and the phase difference between △\[HbO\] and △\[Hb\] will be measured.
Hospital readmissionWithin 30 days after surgeryHospital readmission during the follow up

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026